Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 305

1.

Disrupted salience network functional connectivity and white-matter microstructure in persons at risk for psychosis: findings from the LYRIKS study.

Wang C, Ji F, Hong Z, Poh JS, Krishnan R, Lee J, Rekhi G, Keefe RS, Adcock RA, Wood SJ, Fornito A, Pasternak O, Chee MW, Zhou J.

Psychol Med. 2016 Jul 11:1-13. [Epub ahead of print]

PMID:
27396386
2.

Accuracy of WAAS-Enabled GPS-RF Warning Signals When Crossing a Terrestrial Geofence.

Grayson LM, Keefe RF, Tinkham WT, Eitel JU, Saralecos JD, Smith AM, Zimbelman EG.

Sensors (Basel). 2016 Jun 18;16(6). pii: E912. doi: 10.3390/s16060912.

3.

Impaired Context Processing is Attributable to Global Neuropsychological Impairment in Schizophrenia and Psychotic Bipolar Disorder.

Reilly JL, Hill SK, Gold JM, Keefe RS, Clementz BA, Gershon E, Keshavan MS, Pearlson G, Tamminga CA, Sweeney JA.

Schizophr Bull. 2016 Jun 15. pii: sbw081. [Epub ahead of print]

PMID:
27306316
4.

Interview-based assessment of cognition is a strong predictor of quality of life in patients with schizophrenia and severe negative symptoms.

Cruz BF, Resende CB, Carvalhaes CF, Cardoso CS, Teixeira AL, Keefe RS, Rocha FL, Salgado JV.

Rev Bras Psiquiatr. 2016 Jun 14:0. doi: 10.1590/1516-4446-2015-1776. [Epub ahead of print]

5.

Prenatal Depression: Screening and Referral for Women Who Are Low Income during Antenatal Care.

Mestad R, Lane SD, Hall M, Smith CJ, Carter DB, Rubinstein RA, Keefe RH, Jones-Moore C.

Soc Work Public Health. 2016 Jun 10:1-8. [Epub ahead of print]

PMID:
27286463
6.

Validation of a Computerized test of Functional Capacity.

Keefe RS, Davis VG, Atkins AS, Vaughan A, Patterson T, Narasimhan M, Harvey PD.

Schizophr Res. 2016 Apr 16. pii: S0920-9964(16)30130-X. doi: 10.1016/j.schres.2016.03.038. [Epub ahead of print]

7.

The relationship between negative symptom subdomains and cognition.

Lim J, Lee SA, Lam M, Rapisarda A, Kraus M, Keefe RS, Lee J.

Psychol Med. 2016 Jul;46(10):2169-77. doi: 10.1017/S0033291716000726. Epub 2016 Apr 18.

PMID:
27087476
8.

A Multicenter, Rater-Blinded, Randomized Controlled Study of Auditory Processing-Focused Cognitive Remediation Combined With Open-Label Lurasidone in Patients With Schizophrenia and Schizoaffective Disorder.

Kantrowitz JT, Sharif Z, Medalia A, Keefe RS, Harvey P, Bruder G, Barch DM, Choo T, Lee S, Lieberman JA.

J Clin Psychiatry. 2016 Jun;77(6):799-806. doi: 10.4088/JCP.15m09998.

PMID:
27035157
9.

Predicting Schizophrenia.

Keefe RS, Reichenberg A.

JAMA Psychiatry. 2016 May 1;73(5):441-2. doi: 10.1001/jamapsychiatry.2016.0138. No abstract available.

PMID:
27028053
10.

Treating cognitive impairment in depression: an unmet need.

Keefe RS.

Lancet Psychiatry. 2016 May;3(5):392-3. doi: 10.1016/S2215-0366(16)00095-X. Epub 2016 Mar 16. No abstract available.

PMID:
26995299
11.

Addressing access barriers to services for mothers at risk for perinatal mood disorders: A social work perspective.

Keefe RH, Brownstein-Evans C, Rouland Polmanteer RS.

Soc Work Health Care. 2016;55(1):1-11. doi: 10.1080/00981389.2015.1101045. Epub 2016 Jan 28.

PMID:
26821273
12.

Unitary construct of generalized cognitive ability underlying BACS performance across psychotic disorders and in their first-degree relatives.

Hochberger WC, Hill SK, Nelson CL, Reilly JL, Keefe RS, Pearlson GD, Keshavan MS, Tamminga CA, Clementz BA, Sweeney JA.

Schizophr Res. 2016 Jan;170(1):156-61. doi: 10.1016/j.schres.2015.11.022. Epub 2015 Nov 30.

PMID:
26645510
13.

Assessment of Age-Related Differences in Functional Capacity Using the Virtual Reality Functional Capacity Assessment Tool (VRFCAT).

Atkins AS, Stroescu I, Spagnola NB, Davis VG, Patterson TD, Narasimhan M, Harvey PD, Keefe RS.

J Prev Alzheimers Dis. 2015 Jun;2(2):121-127.

14.

Understanding symbol coding in schizophrenia.

Keefe RS, Harvey PD.

Biol Psychiatry. 2015 Dec 1;78(11):744-6. doi: 10.1016/j.biopsych.2015.09.005. No abstract available.

PMID:
26542742
15.

Latent structure of cognition in schizophrenia: a confirmatory factor analysis of the MATRICS Consensus Cognitive Battery (MCCB).

McCleery A, Green MF, Hellemann GS, Baade LE, Gold JM, Keefe RS, Kern RS, Mesholam-Gately RI, Seidman LJ, Subotnik KL, Ventura J, Nuechterlein KH.

Psychol Med. 2016 Apr;46(5):1119. doi: 10.1017/S0033291715002433. Epub 2015 Nov 5. No abstract available.

PMID:
26537981
16.

Transition to motherhood in women with eating disorders: A qualitative study.

Taborelli E, Easter A, Keefe R, Schmidt U, Treasure J, Micali N.

Psychol Psychother. 2015 Oct 23. doi: 10.1111/papt.12076. [Epub ahead of print]

PMID:
26493834
17.

Report on ISCTM Consensus Meeting on Clinical Assessment of Response to Treatment of Cognitive Impairment in Schizophrenia.

Keefe RS, Haig GM, Marder SR, Harvey PD, Dunayevich E, Medalia A, Davidson M, Lombardo I, Bowie CR, Buchanan RW, Bugarski-Kirola D, Carpenter WT, Csernansky JT, Dago PL, Durand DM, Frese FJ, Goff DC, Gold JM, Hooker CI, Kopelowicz A, Loebel A, McGurk SR, Opler LA, Pinkham AE, Stern RG.

Schizophr Bull. 2016 Jan;42(1):19-33. doi: 10.1093/schbul/sbv111. Epub 2015 Sep 11.

18.

Randomized, Double-Blind, Placebo-Controlled Study of Encenicline, an α7 Nicotinic Acetylcholine Receptor Agonist, as a Treatment for Cognitive Impairment in Schizophrenia.

Keefe RS, Meltzer HA, Dgetluck N, Gawryl M, Koenig G, Moebius HJ, Lombardo I, Hilt DC.

Neuropsychopharmacology. 2015 Dec;40(13):3053-60. doi: 10.1038/npp.2015.176. Epub 2015 Jun 19.

19.

Adjunctive Minocycline in Clozapine-Treated Schizophrenia Patients With Persistent Symptoms.

Kelly DL, Sullivan KM, McEvoy JP, McMahon RP, Wehring HJ, Gold JM, Liu F, Warfel D, Vyas G, Richardson CM, Fischer BA, Keller WR, Koola MM, Feldman SM, Russ JC, Keefe RS, Osing J, Hubzin L, August S, Walker TM, Buchanan RW.

J Clin Psychopharmacol. 2015 Aug;35(4):374-81. doi: 10.1097/JCP.0000000000000345.

PMID:
26082974
20.

Effects of glutamate positive modulators on cognitive deficits in schizophrenia: a systematic review and meta-analysis of double-blind randomized controlled trials.

Iwata Y, Nakajima S, Suzuki T, Keefe RS, Plitman E, Chung JK, Caravaggio F, Mimura M, Graff-Guerrero A, Uchida H.

Mol Psychiatry. 2015 Oct;20(10):1151-60. doi: 10.1038/mp.2015.68. Epub 2015 Jun 16. Review.

PMID:
26077694
Items per page

Supplemental Content

Write to the Help Desk